Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehiko Kitano

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Ophthalmology|March 17, 2017
Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathyMakiko Katagiri, Jun Shoji, Noriko Inada, et al.
American Journal of Ophthalmology|April 5, 2002
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disordersHideharu Funatsu, Hidetoshi Yamashita, Tomohiro Ikeda, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 2002
Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatinHidetaka Noma, Hideharu Funatsu, Hidetoshi Yamashita, et al.
Journal of Medical Economics|December 15, 2018
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in JapanShigehiko Kitano, Taiji Sakamoto, Rei Goto, et al.
Japanese Journal of Ophthalmology|December 7, 2017
Management of diabetic macular edema in Japan: a review and expert opinionHiroko Terasaki, Yuichiro Ogura, Shigehiko Kitano, et al.
Japanese Journal of Ophthalmology|October 20, 2011
Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy, Yukihiro Sato, Noriko Kojimahara, et al.
Diabetes Research and Clinical Practice|November 5, 2002
Retinopathy in older patients with diabetes mellitusSatoshi Kato, Miho Takemori, Shigehiko Kitano, et al.
Journal of Clinical Medicine|November 27, 2021
Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?Yusuke Kameda, Tadashiro Saeki, Ko Hanai, et al.
Current Eye Research|November 4, 2022
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular EdemaYui Tobimatsu, Rie Ogihara, Naoko Endo, et al.
Japanese Journal of Ophthalmology|July 31, 2024
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trialMasahiko Shimura, Hideyasu Oh, Tetsuo Ueda, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Ophthalmology|March 17, 2017
Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathyMakiko Katagiri, Jun Shoji, Noriko Inada, et al.
American Journal of Ophthalmology|April 5, 2002
Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disordersHideharu Funatsu, Hidetoshi Yamashita, Tomohiro Ikeda, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 2002
Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatinHidetaka Noma, Hideharu Funatsu, Hidetoshi Yamashita, et al.
Journal of Medical Economics|December 15, 2018
The impact of anti-vascular endothelial growth factor agents on visual impairment/blindness prevention in patients with diabetic macular edema and on associated patient and caregiver burden in JapanShigehiko Kitano, Taiji Sakamoto, Rei Goto, et al.
Japanese Journal of Ophthalmology|December 7, 2017
Management of diabetic macular edema in Japan: a review and expert opinionHiroko Terasaki, Yuichiro Ogura, Shigehiko Kitano, et al.
Japanese Journal of Ophthalmology|October 20, 2011
Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy, Yukihiro Sato, Noriko Kojimahara, et al.
Diabetes Research and Clinical Practice|November 5, 2002
Retinopathy in older patients with diabetes mellitusSatoshi Kato, Miho Takemori, Shigehiko Kitano, et al.
Journal of Clinical Medicine|November 27, 2021
Is Chronic Kidney Disease Affecting the Postoperative Complications of Vitrectomy for Proliferative Diabetic Retinopathy?Yusuke Kameda, Tadashiro Saeki, Ko Hanai, et al.
Current Eye Research|November 4, 2022
Comparison of the Effect of Bromfenac versus Betamethasone Ophthalmic Solutions in Patients with Diabetic Macular EdemaYui Tobimatsu, Rie Ogihara, Naoko Endo, et al.
Japanese Journal of Ophthalmology|July 31, 2024
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in diabetic macular edema: 2-year results from the Japan subgroup of the phase 3 YOSEMITE trialMasahiko Shimura, Hideyasu Oh, Tetsuo Ueda, et al.
Pageof 5